The role of obesity in inflammatory markers in COVID-19 patients.
The role of obesity in inflammatory markers in COVID-19 patients.
复制标题
DOI:
10.1016/j.orcp.2020.12.004
复制
发表时间:
2021-01
影响因子:
4.3
通讯作者:
Ho JE
中科院分区:
文献类型:
--
作者:
McNeill JN;Lau ES;Paniagua SM;Liu EE;Wang JK;Bassett IV;Selvaggi CA;Lubitz SA;Foulkes AS;Ho JE
Obesity has emerged as a significant risk factor for severe COVID-19 worldwide. Given both COVID-19 infection and obesity have been associated with increased systemic inflammation, we evaluated inflammatory markers in obese and non-obese individuals hospitalized for COVID-19 at Massachusetts General Hospital. We hypothesized that obese patients would have a more exuberant inflammatory response as evidenced by higher initial and peak inflammatory markers along with worse clinical outcomes. Of the 781 patients, 349 were obese (45%). Obese individuals had higher initial and peak levels of CRP and ESR as well as higher peak d-dimer (P < 0.01 for all) in comparison to non-obese individuals, while. IL-6 and ferritin were similar. In addition, obese individuals had a higher odds of requiring vasopressor use (OR 1.54, 95% CI 1.00–2.38, P = 0.05), developing hypoxemic respiratory failure (OR 1.58, 95% CI 1.04–2.40, P = 0.03) and death (OR 2.20, 95% CI 1.31–3.70, P = 0.003) within 28 days of presentation to care. Finally, higher baseline levels of CRP and D-dimer were associated with worse clinical outcomes even after adjustment for BMI. Our findings suggest greater disease severity in obese individuals is characterized by more exuberant inflammation.
登录
查看更多内容
影响因子:
2.6
作者:
Keller, Marla J.;Kitsis, Elizabeth A.;Southern, William
通讯作者:
Southern, William
影响因子:
7.3
作者:
Diao, Bo;Wang, Chenhui;Chen, Yongwen
通讯作者:
Chen, Yongwen
影响因子:
105.7
作者:
Petrilli, Christopher M.;Jones, Simon A.;Horwitz, Leora I.
通讯作者:
Horwitz, Leora I.
影响因子:
14.2
作者:
Herold, Tobias;Jurinovic, Vindi;Weinberger, Tobias
通讯作者:
Weinberger, Tobias
影响因子:
13.8
作者:
Suleyman, Geehan;Fadel, Raef A.;Brar, Indira
通讯作者:
Brar, Indira